{"id":198349,"date":"2024-10-19T12:37:37","date_gmt":"2024-10-19T12:37:37","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/aami-tir102-2019\/"},"modified":"2024-10-25T05:10:41","modified_gmt":"2024-10-25T05:10:41","slug":"aami-tir102-2019","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/aami\/aami-tir102-2019\/","title":{"rendered":"AAMI TIR102 2019"},"content":{"rendered":"
This document provides a mapping of the US FDA 21 CFR requirements to the “regulatory requirements” references in ISO 13485:2016. This mapping is intended to be a tool for US industry to help identify the regulatory requirements from the US medical device regulations to be addressed through an ISO 13485 quality management system.<\/p>\n
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
1<\/td>\n | AAMI TIR102:2019; U.S. FDA 21 CFR mapping to the applicable regulatory requirement references in ISO 13485:2016, \nQuality management systems <\/td>\n<\/tr>\n | ||||||
3<\/td>\n | Title page <\/td>\n<\/tr>\n | ||||||
4<\/td>\n | AAMI Technical Information Report Copyright information <\/td>\n<\/tr>\n | ||||||
5<\/td>\n | Contents <\/td>\n<\/tr>\n | ||||||
6<\/td>\n | Committee representation <\/td>\n<\/tr>\n | ||||||
8<\/td>\n | Foreword <\/td>\n<\/tr>\n | ||||||
9<\/td>\n | Introduction <\/td>\n<\/tr>\n | ||||||
11<\/td>\n | 1 Scope 2 Using this technical information report <\/td>\n<\/tr>\n | ||||||
12<\/td>\n | 3 Key considerations 3.1 Definitions 3.2 Training and Competence 3.3 Approvals vs. Signature 3.4 Risk Management\/Risk-based <\/td>\n<\/tr>\n | ||||||
13<\/td>\n | Table 1: QS Regulation and risk-related Preamble comments 3.5 CAPA vs. Improvement Process 3.6 Additional Resources 3.6.1 Modernization of the standard and harmonization with the QSR <\/td>\n<\/tr>\n | ||||||
15<\/td>\n | Table 2: Comparison from 21 CFR 820 to ISO 13485:2016 <\/td>\n<\/tr>\n | ||||||
99<\/td>\n | Table 3: ISO 13485:2016 to 21 CFR <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" AAMI TIR102:2019 – U.S. FDA 21 CFR mapping to the applicable regulatory requirement references in ISO 13485:2016 Quality Management Systems<\/b><\/p>\n |